These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 13234143)

  • 1. [Decomposition of I-tyrosine by tubercle bacilli. III].
    SHIRAI Y
    Kekkaku; 1954 Nov; 29(11):442-4; English summary, 463. PubMed ID: 13234143
    [No Abstract]   [Full Text] [Related]  

  • 2. The decomposition of L-tyrosine by tubercle bacilli. I.
    SHIRAI Y
    Kekkaku; 1954 Aug; 29(8):295-9; English abstract, 324. PubMed ID: 13212957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Decomposition of l-tyrosine by tubercle bacilli. IV].
    SHIRAI Y
    Kekkaku; 1954 Dec; 29(12):477-81; English summary, 511. PubMed ID: 14354787
    [No Abstract]   [Full Text] [Related]  

  • 4. The decomposition of l-tyrosine by tubercle bacilli. II.
    SHIRAI Y
    Kekkaku; 1954 Sep; 29(9):352-5; English abstract, 375. PubMed ID: 13212965
    [No Abstract]   [Full Text] [Related]  

  • 5. [The decomposition of l-tyrosine by tubercle bacilli (a further study); the formation of N-acetyltyramine, a new compound, from tyramine by tubercle bacilli].
    SHIRAI Y
    Kekkaku; 1955 Nov; 30(11):628-30. PubMed ID: 13286844
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of metabolism in tuberculous lesions. III. Further studies on the decomposition of tyrosine-derivatives by Mycobacterium tuberculosis.
    SAKURAI H
    Acta Tuberc Jpn; 1958 Dec; 8(1-2):32-8. PubMed ID: 13660902
    [No Abstract]   [Full Text] [Related]  

  • 7. [Host lipids in tuberculous infection. III. Long-chain fatty acids against tubercle bacilli (author's transl)].
    Kondo E; Kanai K
    Kekkaku; 1981 Mar; 56(3):109-15. PubMed ID: 6793764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catalase activity of isoniazid-resistant tubercle bacilli. I. Basic experiments in regard to the catalase activity of acid-fast bacilli].
    TOYOHARA M
    Kekkaku; 1957 Sep; 32(9):501-4. PubMed ID: 13482105
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the use of 2,3,5,triphenyltetrazolium chloride in tubercle bacilli sensitivity tests.
    EKHOLM K; BRANDER E
    Ann Med Exp Biol Fenn; 1954; 32(4):426-9. PubMed ID: 14377047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical and genetic studies on nucleic acids extracted from streptomycin resistant avian tubercle bacilli. II].
    SASAKI T
    Kekkaku; 1957 Oct; 32(10):572-4. PubMed ID: 13492369
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on P-ethylsulfonyl-benzaldehyde thiosemicarbazone (PE); influence of PE on the oxygen consumption of human type tubercle bacilli H37 Rv and H37Rv R-PE.
    OKANO M
    Kekkaku; 1954 Aug; 29(8):306-12; English abstract, 235-6. PubMed ID: 13212959
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium tuberculosis PtkA is a novel protein tyrosine kinase whose substrate is PtpA.
    Bach H; Wong D; Av-Gay Y
    Biochem J; 2009 May; 420(2):155-60. PubMed ID: 19366344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The staining characteristics of resistant tubercle bacilli and the relation of morphological changes to the clinical picture. III. The relation of morphological changes of resistant bacilli to clinical picture].
    NAKAMURA S
    Kekkaku; 1958 Aug; 33(8):548-52; English abstract, 579. PubMed ID: 13588763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tyrosine and tryptophan concentration of proteins from antibiotic-resistant and antibiotic-sensitive Mycobacterium tuberculosis Grassberger].
    TANASESCU G; MACELARU A; IONESCU C
    Stud Cercet Inframicrobiol; 1957; 8(3):411-7. PubMed ID: 13529504
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants.
    Gordon SV; Bottai D; Simeone R; Stinear TP; Brosch R
    Bioessays; 2009 Apr; 31(4):378-88. PubMed ID: 19274661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on the virulence of tubercle bacilli using P32-labelled bacilli. 3. The effect of toxic lipid component of virulent tubercle bacilli on the in vivo breakdown of mycobacteria].
    YAMAMURA Y
    Kekkaku; 1958 Aug; 33(8):571-6; English abstract, 581. PubMed ID: 13588768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental studies on the mechanism of infection and immunity in tuberculosis from the standpoint of analysis of streptomycin dependent tubercle bacilli. 2. Studies on the virulence of back mutants from streptomycin dependent tubercle bacilli].
    HASHIMOTO T
    Kekkaku; 1955 May; 30(5):237-41; English summary, 258. PubMed ID: 14392697
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    Wade MM; Zhang Y
    J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubercle bacilli generate a novel cell wall-associated pigment after long-term anaerobic culture.
    Cunningham AF; Ashton PR; Spreadbury CL; Lammas DA; Craddock R; Wharton CW; Wheeler PR
    FEMS Microbiol Lett; 2004 Jun; 235(1):191-8. PubMed ID: 15158281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on kanamycin, a new antibiotic against tubercle bacilli. I. Effect on virulent tubercle bacilli in vitro and in mice.
    YANAGISAWA K; SATO N
    J Antibiot (Tokyo); 1957 Nov; 10(6):233-5. PubMed ID: 13513520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.